VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-15 Cr | ₹15 Cr | ₹26 Cr | ₹-0.15 Cr | ₹-1.17 Cr |
What is the latest Net Cash Inflow / Outflow ratio of VENUS REMEDIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2023 | ₹-15 Cr |
Mar2022 | ₹15 Cr |
Mar2021 | ₹26 Cr |
Mar2020 | ₹-0.15 Cr |
Mar2019 | ₹-1.17 Cr |
How is Net Cash Inflow / Outflow of VENUS REMEDIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2023 | ₹-15 Cr | Negative | |
Mar2022 | ₹15 Cr | -42.89 | |
Mar2021 | ₹26 Cr | Positive | |
Mar2020 | ₹-0.15 Cr | Negative | |
Mar2019 | ₹-1.17 Cr | - |
Compare Net Cash Inflow / Outflow of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹433.2 Cr | -1.4% | -1% | 61.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -1.4% |
-1% |
61.5% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses